GO:1903294 regulation of glutamate secretion, neurotransmission: Synaptic Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903294 describes any biological process that modulates the frequency, rate, or extent of glutamate secretion during neurotransmission.
• Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, and its extracellular concentration is tightly controlled by uptake and release mechanisms.
• Dysregulation of glutamate secretion and signaling is implicated in traumatic brain injury, schizophrenia, PTSD, and metabolic disorders.
• Key molecular players include glutamate transporters (SLC1A1, SLC1A2, SLC1A3), vesicular glutamate transporters (SLC17A6, SLC17A7, SLC17A8), and metabolic enzymes such as GPT2 and GLUL.
• Regulation occurs at multiple levels: presynaptic release probability, transporter trafficking, and metabolic supply of glutamate.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes regulating glutamate secretion.
Description
GO:1903294, regulation of glutamate secretion, neurotransmission, is a biological process term that encompasses any mechanism controlling the frequency, rate, or extent of glutamate release from neurons. Glutamate is the principal excitatory neurotransmitter in the brain, and its precise regulation is essential for normal synaptic transmission, plasticity, and neural circuit function. Because excessive or insufficient glutamate signaling can disrupt neuronal communication, understanding how this process is regulated has broad implications for neurobiology and medicine. Research into GO:1903294 spans molecular, cellular, and systems levels. At the molecular level, glutamate secretion depends on vesicular packaging, calcium sensing, and membrane fusion machinery, while its extracellular levels are shaped by high-affinity transporters that clear glutamate from the synaptic cleft. Activity-dependent and region-specific regulation of extracellular glutamate has been demonstrated in rodent brain slices, highlighting the dynamic nature of this process. Dysregulation of glutamate secretion, neurotransmission is linked to diverse pathologies. Traumatic brain injury models show altered glutamate neurotransmission that contributes to excitotoxicity. In schizophrenia, the cystine/glutamate antiporter system modulates glutamate availability and has been proposed as a biomarker and therapeutic target. Loss of the mitochondrial enzyme GPT2 reprograms synaptic glutamate metabolism, affecting neurotransmission. These examples underscore why GO:1903294 is a critical focus for researchers studying brain function and disease.
regulation of glutamate secretion, neurotransmission At A Glance
| GO ID | GO:1903294 |
|---|---|
| GO term | regulation of glutamate secretion, neurotransmission |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of glutamate release during neurotransmission |
| Related process | Glutamate uptake and clearance by transporters |
| Key cellular sites | Presynaptic terminals, synaptic vesicles, glial cells |
| Example regulators | SLC1A1, SLC1A2, SLC1A3, SLC17A6, SLC17A7, SLC17A8, GPT2, GLUL |
| Disease relevance | Traumatic brain injury, schizophrenia, PTSD, metabolic disorders |
What Is GO:1903294?
According to the Gene Ontology, GO:1903294 (regulation of glutamate secretion, neurotransmission) is defined as any process that modulates the frequency, rate, or extent of glutamate secretion, neurotransmission. In other words, it covers all regulatory inputs that control how much glutamate is released from a neuron and how often, thereby shaping excitatory signaling.
Why Is regulation of glutamate secretion, neurotransmission Important in Cell Biology?
GO:1903294 is important because glutamate is the dominant excitatory neurotransmitter in the mammalian brain, and its secretion must be tightly regulated to prevent excitotoxicity and maintain normal circuit function. Disruptions in this regulation are associated with acute brain injury, psychiatric disorders, and metabolic conditions, making it a key area for both basic neuroscience and translational research.
• Glutamate is the primary excitatory neurotransmitter; its regulated secretion is fundamental to synaptic transmission and plasticity.
• Excessive glutamate release can cause excitotoxicity, a hallmark of traumatic brain injury and neurodegeneration.
• Altered glutamate secretion is implicated in schizophrenia, where the cystine/glutamate antiporter modulates glutamate availability.
• Stress-related disorders such as PTSD involve changes in glutamate neurotransmission that can be targeted by interventions like electroacupuncture.
• Metabolic enzymes such as GPT2 influence synaptic glutamate metabolism, linking energy metabolism to neurotransmission.
• Cell adhesion molecules regulate trafficking and activity of glutamate receptors, indirectly affecting secretion and signaling.
• Region- and activity-dependent regulation of extracellular glutamate highlights the dynamic control of this process.
• Hypothalamic neurons lacking glutamate neurotransmission show altered reproduction and metabolism in a sex-specific manner.
• Understanding GO:1903294 can guide development of therapies for neurological and psychiatric disorders.
• CRISPR models enable precise dissection of genes controlling glutamate secretion.
What Happens During regulation of glutamate secretion, neurotransmission?
Glutamate synthesis and packaging into synaptic vesicles
In simple terms: Glutamate is made and loaded into tiny bubbles called vesicles inside neurons.
Glutamate is synthesized in neurons and packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs), primarily SLC17A6, SLC17A7, and SLC17A8. This packaging step is essential for regulated secretion, as it determines the amount of glutamate available for release. The mitochondrial enzyme GPT2 contributes to synaptic glutamate metabolism, and its loss leads to reprogramming of glutamate handling.
Calcium-dependent vesicle fusion and release
In simple terms: When a neuron fires, calcium enters and triggers vesicles to fuse with the membrane, releasing glutamate.
Action potentials depolarize the presynaptic terminal, opening voltage-gated calcium channels. The resulting calcium influx triggers the fusion of glutamate-filled vesicles with the plasma membrane, releasing glutamate into the synaptic cleft. This process is tightly regulated to control the frequency and amount of glutamate secretion, which is the core of GO:1903294.
Regulation by presynaptic receptors and cell adhesion molecules
In simple terms: Other proteins on the neuron surface can turn glutamate release up or down.
Presynaptic receptors, including metabotropic glutamate receptors and other G-protein-coupled receptors, modulate release probability. Cell adhesion molecules regulate the trafficking and activity of glutamate receptors and can influence presynaptic release machinery. These regulatory inputs adjust the frequency and extent of glutamate secretion in response to activity and developmental cues.
Glutamate clearance by transporters
In simple terms: After release, glutamate is quickly removed from the space between neurons by transporter proteins.
High-affinity glutamate transporters, notably SLC1A1 (EAAC1), SLC1A2 (GLT-1), and SLC1A3 (GLAST), are expressed on neurons and glia and clear glutamate from the extracellular space. This uptake is critical for terminating neurotransmission and preventing excitotoxicity. Region- and activity-dependent regulation of extracellular glutamate has been demonstrated, showing that clearance is dynamically controlled.
Metabolic and activity-dependent modulation
In simple terms: The brain's energy state and recent activity can change how much glutamate is released.
Glutamate secretion is influenced by metabolic status. For example, loss of GPT2 alters synaptic glutamate metabolism and neurotransmission. Additionally, in melanin-concentrating hormone neurons, lack of glutamate neurotransmission affects reproduction and metabolism in a sex-specific manner. These findings illustrate that GO:1903294 integrates metabolic and activity-dependent signals.
Key Genes Involved in GO:1903294 regulation of glutamate secretion, neurotransmission
The following genes and proteins are central to the regulation of glutamate secretion, neurotransmission, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A1 | Neuronal glutamate transporter (EAAC1) that clears extracellular glutamate | Regulates extracellular glutamate levels; linked to neuropsychiatric disorders |
| SLC1A2 | Glial glutamate transporter (GLT-1) responsible for majority of glutamate uptake | Critical for preventing excitotoxicity; target in brain injury |
| SLC1A3 | Glial glutamate transporter (GLAST) that clears glutamate | Modulates synaptic glutamate; involved in cerebellar function |
| SLC17A6 | Vesicular glutamate transporter (VGLUT2) that packages glutamate into vesicles | Essential for glutamate secretion; used to study presynaptic release |
| SLC17A7 | Vesicular glutamate transporter (VGLUT1) that packages glutamate into vesicles | Key marker of glutamatergic neurons; target for secretion studies |
| SLC17A8 | Vesicular glutamate transporter (VGLUT3) with unique expression pattern | Regulates glutamate release in specific neuronal populations |
| GPT2 | Mitochondrial glutamate pyruvate transaminase involved in glutamate metabolism | Loss causes reprogramming of synaptic glutamate metabolism |
| GLUL | Glutamine synthetase that converts glutamate to glutamine in glia | Regulates glutamate recycling and availability |
| GLS | Glutaminase that produces glutamate from glutamine | Supplies glutamate for neurotransmission |
| GRIN1 | NMDA receptor subunit that responds to glutamate | Mediates postsynaptic glutamate signaling; regulated by adhesion molecules |
| GRIN2A | NMDA receptor subunit affecting synaptic plasticity | Target for studies of glutamate receptor trafficking |
| GRIA1 | AMPA receptor subunit mediating fast excitatory transmission | Regulates postsynaptic responses to glutamate |
| SLC7A11 | Cystine/glutamate antiporter (xCT) that exchanges cystine for glutamate | Modulates extracellular glutamate; linked to schizophrenia |
| MCH | Melanin-concentrating hormone neurons that can lack glutamate neurotransmission | Used to study sex-specific effects on reproduction and metabolism |
| CAMK2A | Calcium/calmodulin-dependent kinase II involved in synaptic plasticity | Regulates glutamate receptor activity and trafficking |
| DLG4 | Postsynaptic density protein 95 (PSD-95) that scaffolds glutamate receptors | Organizes postsynaptic signaling complexes |
| GRM2 | Metabotropic glutamate receptor 2 that modulates presynaptic release | Regulates glutamate secretion as an autoreceptor |
| GRM3 | Metabotropic glutamate receptor 3 involved in presynaptic regulation | Target for schizophrenia research |
How Is regulation of glutamate secretion, neurotransmission Regulated?
Regulation of glutamate secretion, neurotransmission (GO:1903294) occurs at multiple levels. Presynaptic autoreceptors, such as metabotropic glutamate receptors, can inhibit or enhance release depending on the circuit. Cell adhesion molecules dynamically regulate the trafficking and activity of glutamate receptors, indirectly influencing secretion. Activity-dependent changes in extracellular glutamate have been observed, indicating that release and uptake are continuously adjusted. Metabolic signals, including those from mitochondrial enzymes like GPT2, can reprogram synaptic glutamate metabolism. Additionally, hormones and sex-specific factors can influence glutamate neurotransmission in specific neuronal populations.
regulation of glutamate secretion, neurotransmission and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC1A2 | Traumatic brain injury, excitotoxicity | Knockout or knockdown in rodent models; overexpression to enhance clearance |
| SLC7A11 | Schizophrenia, glutamate dysregulation | Knockout cells or mice; point mutation to alter transport activity |
| GPT2 | Metabolic reprogramming of synaptic glutamate | Knockout mice; knock-in of human mutations |
| MCH | Reproduction and metabolism alterations | Conditional knockout of glutamate release in MCH neurons |
| GRM2 | Psychiatric disorders, presynaptic regulation | Knockout mice; overexpression in cell models |
Traumatic Brain Injury
Traumatic brain injury (TBI) is associated with excessive glutamate release and impaired uptake, leading to excitotoxicity and neuronal damage. Rodent models of TBI show altered glutamate neurotransmission that contributes to secondary injury. Regulating glutamate secretion is therefore a potential therapeutic strategy in TBI.
Schizophrenia
Schizophrenia has been linked to dysregulation of glutamate signaling. The cystine/glutamate antiporter (SLC7A11) modulates extracellular glutamate levels and has been proposed as a novel biomarker and treatment target in schizophrenia. This highlights the relevance of GO:1903294 to psychiatric disorders.
Post-Traumatic Stress Disorder (PTSD)
PTSD-like behaviors in animal models are associated with altered glutamate neurotransmission. Electroacupuncture has been shown to modulate glutamate neurotransmission and alleviate PTSD-like behaviors, suggesting that regulating glutamate secretion can have therapeutic benefits.
Metabolic and Reproductive Disorders
Lack of glutamate neurotransmission in melanin-concentrating hormone neurons alters mouse reproduction and metabolism in a sex-specific manner. This indicates that GO:1903294 is relevant beyond classical neurotransmission, impacting whole-body physiology.
From regulation of glutamate secretion, neurotransmission-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC1A2 affect glutamate clearance and secretion? | Knockout mouse or CRISPR knockout cell line |
| How do point mutations in SLC7A11 alter glutamate transport? | Point mutation knock-in cells or mice |
| Can overexpression of GLUL reduce excitotoxicity? | Overexpression cell models or viral delivery in rodents |
| What is the role of GPT2 in synaptic glutamate metabolism? | GPT2 knockout mice and tagged knock-in for localization |
| How does lack of glutamate release from MCH neurons affect metabolism? | Conditional knockout of SLC17A6 in MCH neurons |
| Does modulation of glutamate secretion alleviate PTSD-like behaviors? | Animal models with electroacupuncture and glutamate measurements |
How to Study the regulation of glutamate secretion, neurotransmission Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Microdialysis | Extracellular glutamate concentration | In vivo monitoring of glutamate release |
| Fluorescent glutamate sensors | Real-time glutamate dynamics | Imaging in brain slices or cultured neurons |
| CRISPR knockout | Loss-of-function effects | Studying genes like SLC1A2, GPT2 |
| CRISPR knock-in | Point mutations or tags | Modeling disease variants in SLC7A11 |
| RNA-seq | Transcriptome changes | Identifying pathways altered by glutamate regulators |
| Proteomics | Protein expression and modifications | Assessing synaptic protein changes |
| Electrophysiology | Synaptic currents and plasticity | Functional assessment of glutamate transmission |
| Behavioral assays | PTSD-like or metabolic phenotypes | Testing interventions like electroacupuncture |
Measuring Glutamate Release
Glutamate secretion can be measured using microdialysis, amperometric biosensors, or genetically encoded fluorescent sensors. These methods allow real-time monitoring of extracellular glutamate dynamics in brain slices or in vivo.
Genetic Manipulation with CRISPR
CRISPR/Cas9 enables knockout, point mutation, knock-in, and overexpression of genes involved in glutamate secretion. For example, knockout of GPT2 has been used to study synaptic glutamate metabolism, and conditional knockout of vesicular transporters can dissect specific neuronal populations.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify changes in gene expression and protein levels following manipulation of glutamate secretion regulators. Such approaches have revealed reprogramming of metabolic pathways in GPT2 knockout models.
Electrophysiology
Patch-clamp recordings and field potential measurements assess synaptic transmission and plasticity, providing functional readouts of glutamate secretion and receptor activity.
How CRISPR Can Be Used to Study GO:1903294 regulation of glutamate secretion, neurotransmission
Knockout
CRISPR knockout of genes such as SLC1A2, SLC1A3, or GPT2 can reveal their essential roles in regulating glutamate secretion and clearance. For example, GPT2 knockout mice show reprogrammed synaptic glutamate metabolism. Knockout models help establish causality between a gene and GO:1903294.
Point Mutation
Introducing disease-associated point mutations (e.g., in SLC7A11) using CRISPR base editing or homology-directed repair allows precise modeling of altered transporter function and its impact on glutamate secretion.
Knock-in
Knock-in of fluorescent tags or reporter genes (e.g., tagging SLC17A7) enables visualization of vesicular glutamate transporters and tracking of secretion dynamics in live cells.
Overexpression
Overexpression of glutamate transporters like GLT-1 (SLC1A2) or enzymes like GLUL can enhance glutamate clearance and reduce excitotoxicity, providing potential therapeutic strategies.
How EDITGENE Supports regulation of glutamate secretion, neurotransmission Research
Researchers studying regulation of glutamate secretion, neurotransmission-related genes often need to determine whether a candidate gene is causally involved in controlling glutamate release, uptake, or signaling. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of genes implicated in GO:1903294.
Contact EDITGENE today to design your custom CRISPR model for regulation of glutamate secretion, neurotransmission research.
Frequently Asked Questions About regulation of glutamate secretion, neurotransmission
What is GO:1903294?
GO:1903294 is a Gene Ontology term for regulation of glutamate secretion, neurotransmission, defined as any process that modulates the frequency, rate, or extent of glutamate release during neurotransmission.
What genes are involved in regulation of glutamate secretion, neurotransmission?
Key genes include SLC1A1, SLC1A2, SLC1A3 (glutamate transporters), SLC17A6, SLC17A7, SLC17A8 (vesicular transporters), GPT2, GLUL, GLS, and SLC7A11.
How is glutamate secretion regulated?
Glutamate secretion is regulated by presynaptic calcium influx, vesicle fusion machinery, autoreceptors, cell adhesion molecules, and clearance by transporters.
What diseases are associated with dysregulated glutamate secretion?
Traumatic brain injury, schizophrenia, PTSD, and metabolic/reproductive disorders have been linked to altered glutamate neurotransmission.
What is the role of SLC1A2 in glutamate regulation?
SLC1A2 (GLT-1) is a glial glutamate transporter that clears most extracellular glutamate, preventing excitotoxicity.
How can CRISPR be used to study glutamate secretion?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes like GPT2, SLC7A11, and SLC17A6 to test their roles in glutamate secretion.
What methods measure glutamate secretion?
Microdialysis, fluorescent glutamate sensors, electrophysiology, and amperometric biosensors are commonly used to measure glutamate release.
Is GPT2 involved in glutamate neurotransmission?
Yes, loss of mitochondrial GPT2 leads to reprogramming of synaptic glutamate metabolism, affecting neurotransmission.
What is the cystine/glutamate antiporter and its link to schizophrenia?
SLC7A11 (xCT) exchanges cystine for glutamate and modulates extracellular glutamate; it has been proposed as a biomarker and target in schizophrenia.
How does electroacupuncture affect glutamate neurotransmission in PTSD?
Electroacupuncture modulates glutamate neurotransmission and alleviates PTSD-like behaviors in animal models.
Conclusion
GO:1903294, regulation of glutamate secretion, neurotransmission, is a fundamental biological process that controls excitatory signaling in the brain. Its dysregulation contributes to a range of neurological and psychiatric disorders, making it a critical area of research. Advances in CRISPR-based models and functional assays are enabling precise dissection of the genes and pathways involved, offering hope for new therapeutic strategies. EDITGENE provides the tools and expertise to accelerate this research.
References
- 1. Danbolt NC. 2001. Glutamate uptake.. Prog Neurobiol 65(1):1-105 PMID: 11369436
- 2. Hung CC et al.. 2021. Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment.. Int J Mol Sci 22(18) PMID: 34575878
- 3. Dorsett CR et al.. 2017. Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury.. J Neurotrauma 34(2):263-272 PMID: 27256113
- 4. Baytas O et al.. 2024. Loss of mitochondrial enzyme GPT2 leads to reprogramming of synaptic glutamate metabolism.. Mol Brain 17(1):87 PMID: 39604975
- 5. Keable R et al.. 2020. Trafficking and Activity of Glutamate and GABA Receptors: Regulation by Cell Adhesion Molecules.. Neuroscientist 26(5-6):415-437 PMID: 32449484
- 6. Beekly BG et al.. 2025. Lack of glutamate neurotransmission in melanin-concentrating hormone neurons alters mouse reproduction and metabolism in a sex-specific manner.. Biol Sex Differ 16(1):59 PMID: 40770666
- 7. Cai M et al.. 2023. Electroacupuncture modulates glutamate neurotransmission to alleviate PTSD-like behaviors in a PTSD animal model.. Transl Psychiatry 13(1):357 PMID: 37993441
- 8. Pinky NF et al.. 2018. Region- and Activity-Dependent Regulation of Extracellular Glutamate.. J Neurosci 38(23):5351-5366 PMID: 29760178
